Navigation Links
SyntheMed to Present at the Acumen BioFin Conference
Date:11/2/2007

ISELIN, N.J., Nov. 2 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion and drug delivery products, announced today that Robert P. Hickey, President and CEO, will present at the ACUMEN BioFin 9th Annual Healthcare Conference on November 5, 2007 at 5:05 PM, EDT, at the New York Palace Hotel in New York City. Mr. Hickey will present a company overview.

The presentation will be available via web cast for 90 days, beginning on November 5, 2007, and can be viewed by clicking on the following link: http://www.wsw.com/webcast/rrshq12/symd.ob

About SyntheMed, Inc.

SyntheMed, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion and drug delivery products. The Company is primarily focused on the advancement and expansion of product development programs based on its proprietary bioresorbable polymer technology.

Statements in this Press Release that are not statements of historical fact, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Reference is made to the Company's Annual Report on Form 10-KSB for the year ended December 31, 2006 for a description of these, as well as other, risks and uncertainties.


'/>"/>
SOURCE SyntheMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...USNewswire/ -- The Appignani Bioethics Center, a p...a panel discussion today at the National Press Clu...n biomedical sciences and climate change. The topi..., both of the Center for American Progress, who co...les. ,, A video of the event will be made avai...
(Date:11/9/2009)...ber 9 For more than 20 years,resea... development of a,Brain-Computer Interface (BCI). ... brain and a computer. Such a system enables compl...rol devices in their environment just by,mental ac...een supervised by,the researchers themselves to us...
(Date:11/9/2009)... top 10 pharmaceutical giants use Datafarm for pro...a. Datafarm’s announcement comes on the heel...ting where Health Canada stated that, effective im...D regulatory submissions for New Drug Submission (.... , Marlborough, MA (PRWE...
(Date:11/8/2009)...5, 2009 Complete Genomics, a third-generation hum...ication of a report in the journal Science descr...luding analysis of sequence data from three comple...hree genomes sequenced on the proof-of-principle g...overage to $1,726 for 45x coverage for the samples...
Breaking Biology Technology:Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 3intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2
...w Generation,Biofuels Holdings, Inc. (Nasdaq: NGB...hat David Gillespie, President & CEO, is scheduled...Investment Conference on Monday,November 10th, at ...able,for one-on-one meetings during the day. The c...l in New York City. The presentation will be webca...
...oGenomics, Inc.,(OTC Bulletin Board: NGNM) announc...er, Bob Gasparini, will present at the Rodman & Re... from November 10-12, 2008 at,the New York Palace ...se,over 350 small and microcap public life science...r executives of attending companies will make,pres...
...orporation (Nasdaq:,DNDN) today reported results f...or the third quarter of 2008 was $26,000 compared ...07. Revenue for the nine months ended,September 30...ne months,ended September 30, 2007., Dendreon,s t...008 were,$17.3 million compared to $19.8 million i...
Other Biology Technology:New Generation Biofuels CEO to Present at the Rodman & Renshaw Annual Global Investment Conference 2NeoGenomics to Present at the Rodman & Renshaw Healthcare Conference on November 10 2Dendreon Reports Third Quarter 2008 Financial Results 2Dendreon Reports Third Quarter 2008 Financial Results 3Dendreon Reports Third Quarter 2008 Financial Results 4Dendreon Reports Third Quarter 2008 Financial Results 5
(Date:11/9/2009)...HILADELPHIA Scientists and industry leaders from ... 2009, for the AACR-NCI-EORTC Molecular Targets an...ich will feature groundbreaking information on imp...er is a complex disease and to treat it effectivel...that takes place at the molecular level," said Lew...
(Date:11/8/2009)... HEALTH EDUCATION DESIGNED FOR ADULTS WITH INTEL... LIVES , An Indiana University study involving ...he adults increased their personal health knowledg... , Adults with ID, an internationally accepted ...rates of obesity, physical inactivity and preventa...
(Date:11/6/2009)..., DETROIT, Nov. 6 Auburn Hills, M...LEID) will be installing its locker system and pat...ACS) at the U.S. Department of Health and Human Se...in Bethesda, MD. The locker system will support t...or protecting our nation,s medical research agency...
Breaking Biology News(10 mins):Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Bio enabled surface mediated approach produces nanoparticle composites 13633 1Bio enabled surface mediated approach produces nanoparticle composites 13633 2Bio enabled surface mediated approach produces nanoparticle composites 13633 3Living longer and happier 54930 1Living longer and happier 54930 2Kaiser Workers Launch Statewide Pickets 54929 1
... Depression, anxiety disorders such as panic diso...and drug dependence, dementia and Parkinsons disea...ain. The size, the burden and cost of brain disord...erestimated, as Prof. Dr. Hans Ulrich Wittchen ,em...0th ECNP Congress for ,Neuropsychopharmacology in ...
... Even early in adulthood, aging begins to slow th... altogether, suggests a Princeton University study...roscientists has found that soon after marmoset mo...l cells form in the hippocampus region of the anim...associated with both learning and memory. While ot...
... PHILADELPHIA, PA, October 15, 2007- Clinical dat...rican College of Gastroenterology (ACG) show that ...lectomy surgeries for patients with moderately to ...g to a primary analysis of long-term extension dat...s (ACT trials), there is a 41 percent reduction in...
Other Biology News:Mental disorders are disorders of the brain 2Mental disorders are disorders of the brain 3Brain cell growth diminishes long before old age strikes, animal study shows 2Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients 2Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients 3Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients 4Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients 5Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients 6
Agilent ChemStation Base Software from Agilent Technologies
Mouse Anti-HLA, Class II Antigen-DR+DP Monoclonal Antibody, Unconjugated, Clone 236-14240 from Meridian Life Science, Inc.
...lly clear polystyrene with frosted labeling surfac...s for cell counting. 100% integrity tested. Linkag...d to easily match Cornings product number. If show...d Sigma-Aldrich number (C0177) or contact customer...
Rabbit Anti-iNOS / NOS Type II Polyclonal Antibody, Unconjugated from BD Biosciences Pharmingen
Biology Products: